Literature DB >> 14641603

Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children.

Malin F Böttcher1, Jenny Bjurström, Xiao-Mei Mai, Lennart Nilsson, Maria C Jenmalm.   

Abstract

Atopic asthma is characterized by excessive T helper 2 (Th2)-like immunity to allergens in the bronchial mucosa. The Th2-cytokine interleukin (IL)-4 induces IgE production, while the Th2-cytokine IL-5 promotes eosinophilic inflammation in the airways of asthmatics. Most asthmatics are atopic, but a subgroup is non-atopic. We hypothesize that allergen-induced Th2, particularly IL-5, responses can be observed in peripheral blood in both atopic and non-atopic asthmatic children but not in healthy control children. The aim of the present study was to determine IL-4, IL-5, IL-9, IL-10, IL-13 and IFN-gamma secretion induced from peripheral blood mononuclear cells (PBMC) by a broad panel of inhalant allergens (timothy, cat, birch, dog and house dust mite) in asthmatic children with and without sensitization. The study included 13 atopic asthmatic, 5 non-atopic asthmatic, and 12 non-atopic non-asthmatic children. PBMC were stimulated with allergens and cytokine production was measured with enzyme-linked immunosorbent assay (ELISA). Higher levels of cat and dog antigen-induced IL-5 release were more commonly observed in both atopic and non-atopic asthmatics than in controls. Children with atopic, but not non-atopic, asthma produced higher levels of allergen-induced IL-4 and IL-9 than controls. Non-atopic asthmatics produced more IL-10 than atopic asthmatics after cat stimulation. High levels of eosinophilia-associated IL-5 responses are induced by cat and dog allergen in both atopic and non-atopic asthmatic children. The Th2 cytokines IL-4 and IL-9 were associated only with atopic asthma, probably due to their IgE-inducing properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641603     DOI: 10.1034/j.1399-3038.2003.00061.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  8 in total

1.  Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis.

Authors:  Kiyoshi Yamazaki; Joseph A Murray; Amindra S Arora; Jeffery A Alexander; Thomas C Smyrk; Joseph H Butterfield; Hirohito Kita
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

2.  Transforming growth factor beta (TGFβ1) in breast milk and indicators of infant atopy in a birth cohort.

Authors:  Christine L M Joseph; Suzanne Havstad; Kevin Bobbitt; Kimberley Woodcroft; Edward M Zoratti; Christian Nageotte; Rana Misiak; Robert Enberg; Charlotte Nicholas; Jerel M Ezell; Dennis R Ownby; Christine Cole Johnson
Journal:  Pediatr Allergy Immunol       Date:  2014-02-13       Impact factor: 6.377

Review 3.  Th9 cells: differentiation and disease.

Authors:  Mark H Kaplan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

Review 4.  Epigenome-modifying tools in asthma.

Authors:  Peter O Brook; Mark M Perry; Ian M Adcock; Andrew L Durham
Journal:  Epigenomics       Date:  2015-10-07       Impact factor: 4.778

5.  Sensitization to storage proteins in peanut and hazelnut is associated with higher levels of inflammatory markers in asthma.

Authors:  Jennifer Johnson; Andrei Malinovschi; Jonas Lidholm; Carl Johan Petersson; Lennart Nordvall; Christer Janson; Kjell Alving; Magnus P Borres
Journal:  Clin Mol Allergy       Date:  2020-06-23

6.  Serum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness.

Authors:  Bernard Panaszek; Ewa Liebhart; Jerzy Liebhart; Robert Pawłowicz; Andrzej M Fal
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

7.  In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response.

Authors:  K A Whalen; H Legault; C Hang; A Hill; M Kasaian; D Donaldson; G W Bensch; G Bensch; J Baker; P S Reddy; N Wood; M K Ramarao; D K Ellis; C Csimma; C McKee; J D Clark; J Ryan; A J Dorner; M O'Toole
Journal:  Clin Exp Allergy       Date:  2008-07-28       Impact factor: 5.018

Review 8.  Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation?

Authors:  Todd D Terhune; Richard C Deth
Journal:  Int J Environ Res Public Health       Date:  2018-05-03       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.